NM_000284.4:c.*1195_*1196delCA
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_000284.4(PDHA1):c.*1195_*1196delCA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0134 in 1,174,388 control chromosomes in the GnomAD database, including 97 homozygotes. There are 4,748 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0091 ( 7 hom., 274 hem., cov: 23)
Exomes 𝑓: 0.014 ( 90 hom. 4474 hem. )
Consequence
PDHA1
NM_000284.4 3_prime_UTR
NM_000284.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.979
Publications
0 publications found
Genes affected
PDHA1 (HGNC:8806): (pyruvate dehydrogenase E1 subunit alpha 1) The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 alpha 1 subunit containing the E1 active site, and plays a key role in the function of the PDH complex. Mutations in this gene are associated with pyruvate dehydrogenase E1-alpha deficiency and X-linked Leigh syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010]
MAP3K15 (HGNC:31689): (mitogen-activated protein kinase kinase kinase 15) The protein encoded by this gene is a member of the mitogen-activated protein kinase (MAPK) family. These family members function in a protein kinase signal transduction cascade, where an activated MAPK kinase kinase (MAP3K) phosphorylates and activates a specific MAPK kinase (MAP2K), which then activates a specific MAPK. This MAP3K protein plays an essential role in apoptotic cell death triggered by cellular stresses. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant X-19360844-AAC-A is Benign according to our data. Variant chrX-19360844-AAC-A is described in ClinVar as Likely_benign. ClinVar VariationId is 445325.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00915 (1026/112183) while in subpopulation NFE AF = 0.0151 (802/53218). AF 95% confidence interval is 0.0142. There are 7 homozygotes in GnomAd4. There are 274 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 XL,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PDHA1 | NM_000284.4 | c.*1195_*1196delCA | 3_prime_UTR_variant | Exon 11 of 11 | ENST00000422285.7 | NP_000275.1 | ||
| MAP3K15 | NM_001001671.4 | c.3858-13_3858-12delGT | intron_variant | Intron 28 of 28 | ENST00000338883.9 | NP_001001671.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PDHA1 | ENST00000422285.7 | c.*1195_*1196delCA | 3_prime_UTR_variant | Exon 11 of 11 | 1 | NM_000284.4 | ENSP00000394382.2 | |||
| MAP3K15 | ENST00000338883.9 | c.3858-13_3858-12delGT | intron_variant | Intron 28 of 28 | 5 | NM_001001671.4 | ENSP00000345629.4 |
Frequencies
GnomAD3 genomes AF: 0.00915 AC: 1026AN: 112131Hom.: 7 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
1026
AN:
112131
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00828 AC: 1398AN: 168882 AF XY: 0.00771 show subpopulations
GnomAD2 exomes
AF:
AC:
1398
AN:
168882
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0138 AC: 14703AN: 1062205Hom.: 90 AF XY: 0.0135 AC XY: 4474AN XY: 332309 show subpopulations
GnomAD4 exome
AF:
AC:
14703
AN:
1062205
Hom.:
AF XY:
AC XY:
4474
AN XY:
332309
show subpopulations
African (AFR)
AF:
AC:
30
AN:
25188
American (AMR)
AF:
AC:
100
AN:
31441
Ashkenazi Jewish (ASJ)
AF:
AC:
143
AN:
18575
East Asian (EAS)
AF:
AC:
0
AN:
29915
South Asian (SAS)
AF:
AC:
3
AN:
51407
European-Finnish (FIN)
AF:
AC:
574
AN:
40115
Middle Eastern (MID)
AF:
AC:
10
AN:
4032
European-Non Finnish (NFE)
AF:
AC:
13362
AN:
816757
Other (OTH)
AF:
AC:
481
AN:
44775
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
477
954
1430
1907
2384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00915 AC: 1026AN: 112183Hom.: 7 Cov.: 23 AF XY: 0.00798 AC XY: 274AN XY: 34341 show subpopulations
GnomAD4 genome
AF:
AC:
1026
AN:
112183
Hom.:
Cov.:
23
AF XY:
AC XY:
274
AN XY:
34341
show subpopulations
African (AFR)
AF:
AC:
71
AN:
30913
American (AMR)
AF:
AC:
45
AN:
10578
Ashkenazi Jewish (ASJ)
AF:
AC:
23
AN:
2644
East Asian (EAS)
AF:
AC:
0
AN:
3542
South Asian (SAS)
AF:
AC:
0
AN:
2730
European-Finnish (FIN)
AF:
AC:
77
AN:
6126
Middle Eastern (MID)
AF:
AC:
1
AN:
219
European-Non Finnish (NFE)
AF:
AC:
802
AN:
53218
Other (OTH)
AF:
AC:
5
AN:
1527
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
39
78
118
157
196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Feb 20, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.